ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+7.15%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$4.06B
AUM Growth
+$411M
(+11%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
5.72%
Top 10 Holdings %
Top 10 Hldgs %
21.64%
Holding
1,420
New
288
Increased
397
Reduced
560
Closed
115
Top Buys
| 1 |
Vanguard Long-Term Bond ETF
BLV
|
+$158M |
| 2 |
iShares Core US REIT ETF
USRT
|
+$141M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$138M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$101M |
| 5 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$69.2M |
Top Sells
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$731M |
| 2 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$487M |
| 3 |
NVIDIA
NVDA
|
+$38.6M |
| 4 |
Verizon
VZ
|
+$19.7M |
| 5 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$18.9M |
Sector Composition
| 1 | Technology | 20.92% |
| 2 | Energy | 10.24% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 5.82% |
| 5 | Consumer Discretionary | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
876
Bicycle Therapeutics
BCYC
$485M
| $135K | ﹤0.01% |
+5,276
| New | +$135K |
|
|
INBX
877
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $134K | ﹤0.01% |
+5,165
| New | +$134K |
|
878
Erasca
ERAS
$440M
| $134K | ﹤0.01% |
+48,513
| New | +$134K |
|
|
IPHA
879
Innate Pharma
IPHA
$190M
| $133K | ﹤0.01% |
+42,431
| New | +$133K |
|
880
IDEAYA Biosciences
IDYA
$2.17B
| $133K | ﹤0.01% |
+5,650
| New | +$133K |
|
881
BioNTech
BNTX
$25.1B
| $133K | ﹤0.01% |
+1,230
| New | +$133K |
|
882
Toll Brothers
TOL
$13.8B
| $133K | ﹤0.01% |
1,677
+191
| +13% | +$15.1K |
|
883
DuPont de Nemours
DD
$32.7B
| $132K | ﹤0.01% |
1,852
+1,829
| +7,952% | +$131K |
|
884
ImmunityBio
IBRX
$2.45B
| $132K | ﹤0.01% |
+47,540
| New | +$132K |
|
885
Xencor
XNCR
$596M
| $131K | ﹤0.01% |
+5,228
| New | +$131K |
|
|
SWTX
886
DELISTED
SpringWorks Therapeutics
SWTX
| $130K | ﹤0.01% |
+4,972
| New | +$130K |
|
887
Tango Therapeutics
TNGX
$708M
| $130K | ﹤0.01% |
+39,158
| New | +$130K |
|
888
ON Semiconductor
ON
$19.7B
| $128K | ﹤0.01% |
1,355
-1
| -0.1% | -$95 |
|
889
CubeSmart
CUBE
$9.29B
| $128K | ﹤0.01% |
2,868
-1,939
| -40% | -$86.6K |
|
|
PNT
890
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $128K | ﹤0.01% |
+14,102
| New | +$128K |
|
|
ITOS
891
DELISTED
iTeos Therapeutics
ITOS
| $127K | ﹤0.01% |
+9,624
| New | +$127K |
|
|
IGMS
892
DELISTED
IGM Biosciences
IGMS
| $127K | ﹤0.01% |
+13,800
| New | +$127K |
|
893
MacroGenics
MGNX
$109M
| $126K | ﹤0.01% |
+23,534
| New | +$126K |
|
894
Cullinan Oncology
CGEM
$382M
| $125K | ﹤0.01% |
+11,661
| New | +$125K |
|
895
Kymera Therapeutics
KYMR
$3.11B
| $125K | ﹤0.01% |
+5,440
| New | +$125K |
|
896
Xenon Pharmaceuticals
XENE
$2.86B
| $125K | ﹤0.01% |
+3,247
| New | +$125K |
|
897
Day One Biopharmaceuticals
DAWN
$744M
| $124K | ﹤0.01% |
+10,413
| New | +$124K |
|
898
PPG Industries
PPG
$24.6B
| $124K | ﹤0.01% |
837
+826
| +7,509% | +$122K |
|
899
Allogene Therapeutics
ALLO
$260M
| $124K | ﹤0.01% |
+24,937
| New | +$124K |
|
900
Precigen
PGEN
$1.23B
| $124K | ﹤0.01% |
+107,685
| New | +$124K |
|